News reports (and apparently a media release) have been suggesting that ‘A prostate cancer treatment using permanently implanted radioactive “seeds” doubles rates of 5-year tumor-free survival compared with conventional high-dose radiotherapy.’ Unfortunately, these reports are somewhat — or perhaps very — misleading. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: ASCENDE-RT, boost, brachytherapy, external beam, low-dose, radiation | 9 Comments »
An article just published by Grimm et al. in a supplement to BJU International argues (quite persuasively) that low-dose brachytherapy is the best form of treatment for men with low-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: brachytherapy, comparative, low risk, low-dose, outcome | 1 Comment »
It has been suggested that, after an initial “loading dose” for a period of time, abiraterone acetate could potentially be used to treat metastatic, castration-resistant prostate cancer (mCRPC) at a much lower daily maintenance dose than that currently approved. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: abiraterone, low-dose, maintenance | 19 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 